After the Diane 35 and the Androcur, two new contraceptive pills are in the viewfinder of the health authorities: Lotényl and Lotéran.

Alerting since early 2019 women on the risk of meningioma-a tumor of the membranes that surround the brain, benign in most cases-associated with their prolonged and high use, the National Agency for Medicines and Health Products (ANSM) has decided to launch a public consultation to raise the experiences, she announced in a statement published on its site, Thursday, September 24.

Concretely, "anyone or structure who wishes to express their opinion on the use of these drugs or share their experience is invited to apply between Thursday 10 and Wednesday 30 September 2020 to be able to be auditioned on Monday, November 2," , specifies the agency . These hearing, filmed, will be broadcast live on the ANSM Youtube channel.

After a vast epidemiological study, the health authorities published in June a warning concerning these two treatments and their generics, which increase the risk of meningioma. This study “made it possible to quantify this risk for the first time: a woman who takes one of these treatments for more than six months has approximately 3.3 times more risk of developing meningiom compared to the basic risk; The risk increases with the duration of treatment, and also with the dose used and the age of the patient: under Lotényl, the risk is multiplied by 12.5 from five years of treatment, under Luteran, it is multiplied by 7 for 3.5 years of treatment, " write the health authorities.

The ANSM also publishes preliminary recommendations on its site for patients processed by Lutényl, Lotéran or their generics, invited to consult their doctor, who may, depending on the treatment of treatment, propose to carry out brain imaging.
Article here: https://www.lemonde.fr/sante/article/2020/09/25/pilules-contraceptifs-lutenyl-et-luteran-dans-le-visseur-de-l-ansm-pour-des-risques-de-meningiome_6053574_1651302.html

Note from the association: We can be surprised that these two treatments are indicated as "contraceptive pill" in the article, while these are not indications for which the laboratories put them on the market!
Ditto for the article in Parisian: https://www.leparisien.fr/societe/sante/risque-de-meningiome-l-agénce-dedicament-alerte-sur-le-lutenyl-et-le-luteran-26-09-2020-8392035.php

As for the communication of the Marie-Claire newspaper, they are still to say that the progestins are just "suspected of promoting" brain tumors !!!
https://www.marieclaire.fr/luteran-lutenyl-meningiome-tameur-cerebrale-consultation-publique-ansm,1357150.asp